Community Research and Development Information Service - CORDIS

Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis

From 2018-10-01 to 2020-03-31, ongoing project

Project details

Total cost:

EUR 150 802,50

EU contribution:

EUR 150 000

Coordinated in:

Netherlands

Call for proposal:

ERC-2018-PoCSee other projects for this call

Funding scheme:

ERC-POC - Proof of Concept Grant

Objective

Host Institution

UNIVERSITEIT MAASTRICHT
Netherlands

EU contribution: EUR 150 000


Minderbroedersberg 4-6
6200 MD MAASTRICHT
Netherlands
See on map
Activity type: Higher or Secondary Education Establishments

Contact the organisation

Beneficiaries

UNIVERSITEIT MAASTRICHT
Netherlands

EU contribution: EUR 150 000


Minderbroedersberg 4-6
6200 MD MAASTRICHT
Netherlands
See on map
Activity type: Higher or Secondary Education Establishments

Contact the organisation

To know more

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top